Biotechnology company Synthetics Biologics expanded its Irritable Bowel Syndrome Clinical Advisory Board with the appointment of four GI physicians. The new advisory board members include:
• William Chey, MD, director of the GI Physiology Laboratory and co-director of the Michigan Bowel Control Program at the University of Michigan in Ann Arbor
• Gail M. Corner, MD, a board-certified gastroenterologist and hepatologist with experience in the pharmaceutical industry
• Anthony J. Lembo, MD, associate professor of medicine at Harvard Medical School and director of the GI Motility Laboratory at the Beth Israel Deaconess Medical Center, both in Boston
• Philip Schoenfeld, MD, MSED, MSc, professor of medicine at the University of Michigan School of Medicine and director of the university’s Gastrointestinal Epidemiology Training Program
Blue Cross and Blue Shield of Illinois and Illinois Gastroenterology Group in Elgin partnered to create an intensive medical home program focused on Crohn’s disease. Illinois Gastroenterology Group physician Lawrence Kosinski, MD, MBA, discussed the partnership in a news release.
More articles on gastroenterology:
Menthol spray shown to improve ADR, reduce peristalsis
11 statistics on gastroenterologist & payer relationships
3 ways gastroenterologists can demonstrate value
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
